Abstract. Cytoskeletal abnormalities with accumulation of ubiquilated inclusions in the anterior horn cells are a pathological hallmark of both familial and sporadic amyotrophic lateral sclerosis (ALS) and of mouse models for ALS. Phosphorylated neurofilaments besides ubiquitin and dorfin have been identified as one of the major components of the abnormal intracellular perikaryal aggregates. As we recently found that p38 mitogen-activated protein kinase (p38MAPK) colocalized with phosphorylated neurofilaments in spinal motor neurons of SOD1 mutant mice, a model of familial ALS, we investigated whether this kinase also contributed to the inclusions found in ALS patients and SOD1 mutant mice. Intense immunoreactivity for activated p38MAPK was observed in degenerating motor neurons and reactive astrocytes in ALS cases. The intracellular immunostaining for activated p38MAPK appeared in some neurons as filamentous skein-like and ball-like inclusions, with an immunohistochemical pattern identical to that of ubiquitin. Intracellular p38MAPK-positive aggregates containing ubiquitin and neurofilaments were also found in the spinal motor neurons of SOD1 mutant mice. Our observations indicate that activation of p38MAPK might contribute significantly to the pathology of motor neurons in ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a late-onset neurodegenerative disease characterized by selective degeneration and death of motor neurons in spinal cord, brainstem, and cerebral cortex. About 10% of ALS cases are familial, with one fifth linked to various dominantly inherited mutations of the gene encoding the copper-zinc superoxide dismutase (SOD1) (1, 2) . The clinical and pathological expression of ALS is similar between familial and sporadic forms. A hallmark of all types of ALS is the cytoplasmic accumulation of ubiquitylated skein-like inclusions in motor neurons of the spinal cord (3) (4) (5) . Lewy body-like inclusions, although not typical for ALS, are also found. Besides phosphorylated neurofilaments and ubiquitin, the latter inclusions contain Cdk5 kinase (6, 7) . Neurofilament proteins, together with peripherin and kinesin, are also detected in the majority of spheroids, i.e. the axonal swellings of motor neurons (8) (9) (10) . More recently, dorfin, a RING finger-type E3 ubiquitin ligase, has also been localized in the inclusion bodies found in the motor neurons and neuronal processes of familial and sporadic ALS (11, 12) Altogether, these inclusions are likely to be responsible for the dysfunction and progressive degeneration of motor neurons (13 from various in vitro and in vivo models suggest that phosphorylation of neurofilaments is critical in their aggregation process; however, the kinase(s) involved remain to be identified.
The pathology of ALS, including formation of the abnormal intracellular inclusions, is strikingly mimicked by several lines of transgenic mice overexpressing the human ALS-linked SOD1 gene mutations (14, 15) . Several hypotheses have been proposed to explain the selective motor neuron toxicity linked to mutant SOD1, including elevated oxidative stress, glutamate excitotoxicity and cytoskeletal abnormalities (13, 16) . Recently, we found a remarkable activation of p38 mitogen-activated protein kinase (p38MAPK) in the spinal cord of transgenic mice carrying the human G93A SOD1 gene mutation (TgSOD1G93A), during the progression of disease (17) . p38MAPK is an important mediator of signal transduction in response to a variety of extracellular stimuli and is implicated in diverse functions, including phosphorylation of cytoskeletal proteins (18, 19) . Interestingly, in motor neurons of Tg-SOD1G93A mice at the initial phase of disease, we observed increased labeling of p38MAPK that colocalized with phosphorylated neurofilaments in degenerating perikarya and neurites, suggesting a role of this kinase in neurofilament phosphorylation (17) . In this report we used immunohistochemical tools to investigate the localization of activated p38MAPK in the intracellular inclusions of sporadic human ALS and SOD1 mutant mice.
MATERIALS AND METHODS

Human Tissues
Spinal cords from sporadic ALS (n ϭ 5, mean age at death 59 years) and control patients affected by non-neurological diseases (n ϭ 5, mean age at death 66 years) were used (Table) . Abbreviations: sALS ϭ sporadic amyotrophic lateral sclerosis; NC ϭ normal control; PMI ϭ postmortem interval. Duration of illness in ALS cases ranged between 10 and 60 months. All cases had been autopsied within 8 to 15 hours from death. Tissues were fixed in formalin and embedded in paraffin.
Mouse Tissues
Female C57BL/6 and transgenic mice were maintained at a temperature of 21 Ϯ 1ЊC with relative humidity 55% Ϯ 10% and 12 hours of light. Food (standard pellets) and water were supplied ad libitum. Transgenic mice originally obtained from Jackson Laboratories (Bar Harbor, ME) and expressing high copy number of mutant human SOD1 with a Gly 93 Ala substitution (TgSOD1G93A) were bred and maintained on a C57BL/6 mice strain at the Consorzio Mario Negri Sud (S. Maria Imbaro, Italy). Transgenic mice were identified by polymerase chain reaction (PCR) (1). These mice become symptomatic at around 11 weeks and die at about 21 to 22 weeks of age. A 52% Ϯ 5% (SE) motor neuron loss is found in the oldest mice compared to age-matched controls (20) . Female mice were killed at 10 and 14 weeks of age corresponding respectively to a presymptomatic and early symptomatic stage of the progression of the motor dysfunction. Tg SOD1 G93A (n ϭ 18) and non-transgenic (n ϭ 6) mice combined in age groups of 9, 14, and 19 weeks were fixed by perfusion with 4% paraformaldehyde and their spinal cords embedded in paraffin for light microscopy or in hydrophilic resin (LR white acrylic resin, Sigma, Poole, UK) for electron microscopy.
Procedures involving animals and their care were conducted in conformity with the institutional guidelines that are in compliance with national and international laws and policies and all efforts were made to minimize the number of animals used and their suffering.
Immunocytochemistry
All light microscopic analyses were performed on 5-m sections from cervical and lumbar spinal cord. To detect p38MAPK, we used a polyclonal antibody that selectively recognizes its activated (phosphorylated) form (1/100 dilution, New England Biolabs, Beverly, MA or 1/500 dilution, Calbiochem, Nottingham, UK). Other primary antibodies used in the study were a polyclonal anti-phosphorylated JNK (1/100, New England Biolabs), a monoclonal anti-ubiquitin (1/5000, Chemicon International, Harrow, UK), a mouse monoclonal antiphosphorylated neurofilaments (SMI 31, 1/5000, Sternberger, Lutherville, MD). In some cases, sections were treated with trypsin before immunostaining. Specificity of p38MAPK immunoreactivity was tested by preadsorbing the primary antibody with the immunizing peptide (kindly provided by Dr. A. Nelsbach, New England Biolabs). Complete abolishment of the staining was achieved using 0.5 g/ml of the antibody and 50 g/ml of the peptide. Immune reactions were revealed by streptABC using either DAB or AEC as peroxidase substrate. Sections were counterstained with hematoxylin. For double labeling studies, serial sections were used or, alternatively, sections were first immunostained for p38MAPK with AEC as substrate and photographed. After ethanol decoloration and elution of anti-p38MAPK antibody with HCl, sections were immunostained with another primary antibody using DAB as substrate. For electron microscopy, thin sections of the ventral horn were collected on Formvar-coated nickel grids and processed with a standard post-embedding immunogold staining protocol. Briefly, the grids were incubated overnight in either 1) a polyclonal anti-phosphorylated p38MAPK antiserum (1/250, Calbiochem, Nottingham, UK), 2) a monoclonal anti-ubiquitin antiserum (1/1000, Chemicon International, Harrow, UK), or 3) a mixture of the 2 primary antisera. After being thoroughly rinsed in buffers, the grids were incubated for 1 hour at room temperature in a goat-anti rabbit secondary antiserum conjugated to 15 nm gold particles (British Biocell International, Cardiff, UK) (to detect p38MAPK) or in a goat-anti mouse secondary antiserum conjugated to 15 nm gold particles (to detect ubiquitin), whereas for double labeling the grids were first incubated in a biotinylated goat-anti rabbit secondary antiserum and then in a mixture of streptavidin conjugated to 5 nm gold particles (to detect p38MAPK) and of a goat-anti mouse secondary antiserum conjugated to 15 nm gold particles (to detect ubiquitin). Control grids were processed in the same way, with omission of the primary antiserum. All grids were counterstained with aqueous uranyl acetate and lead citrate and then observed and photographed with a Jeol T8 electron microscope.
RESULTS
Some of the present series of ALS cases had been previously analyzed for the expression of the JNK family of MAPKs and of the transcription factor NFB (21). To examine if p38MAPK had the same expression pattern of JNK, serial sections of spinal cord were consecutively immunostained for the 2 MAPKs. In control tissues, immunoreactivity for p38MAPK reflected that of JNK, showing light cytoplasmic staining in motor neurons (Fig.  1Aa) . Striking upregulation of p38MAPK occurred in ALS spinal cord (Fig. 1Ab) . Similar to JNK, p38MAPK was abundantly expressed by reactive astrocytes in the anterior horns and pyramidal tracts, i.e. the areas characterized by prominent gliosis in ALS (Fig. 1Ac) . At variance with JNK, however, strong p38MAPK immunoreactivity was also found in the majority of motor neurons, with the highest staining intensity in atrophic and degenerating neurons.
As shown in Figure 1B , some motor neurons showed a perikaryal distribution of p38MAPK immunoreactivity that appeared as filamentous aggregates of various complexities. In some cases, the labeled filamentous inclusions were organized in a circular pattern around the nucleus, or in arrays located in the peripheral region of the neuron and in neurites. A comparison between ubiquitin and p38MAPK immune reactivity showed a striking similarity in the morphology of the labeled inclusions (Fig.  1C) .
As we have previously shown (17), p38MAPK was constitutively activated in the substantia gelatinosa of dorsal horns in both wild type and Tg SOD1 G93A mice, while weak staining for p38MAPK was found in motor neurons of control mice. On the contrary, Tg SOD1 G93A mice showed a striking activation of p38MAPK in motor neurons ( Fig. 2A) that was more pronounced in degenerating ones. Vacuolated motor neurons showed prominent activation of p38MAPK that persisted even in end stages of destruction (Fig. 2Ab) . Reactive glial cells located at the border of large vacuoles were also strongly p38MAPK-immunoreactive (Fig. 2Ac) .
More advanced stages in Tg SOD1 G93A mice are characterized by progressive accumulation of cytoplasmic inclusions. Analysis of sections revealed a large number of p38MAPK-positive inclusions in the ventral horns (Fig. 2Ba) and less frequently in the intraspinal portion of the ventral roots (Fig. 2Bb) .
To evaluate p38MAPK colocalization with other molecules found in the aggregates, we performed double labeling studies using antibodies to p38MAPK, ubiquitin, and phosphorylated neurofilaments. The analysis revealed that p38MAPK-positive inclusions also contained ubiquitin (Fig. 2B, c-d ) and phosphorylated neurofilaments (Fig. 2B, e-f) .
To confirm the light microscopic data, we performed an ultrastructural investigation on the ventral horn of Tg SOD1 G93A mice. Selective deposition of gold particles, indicating p38MAPK immunolabeling, was found on cytoplasmic aggregates consisting of irregularly oriented filaments (Fig. 3A) . In adjacent sections, similar filamentous aggregates appeared labeled by the anti-ubiquitin antiserum (Fig. 3B) . Double labeling on the same thin section revealed that p38MAPK-positive aggregates also contained ubiquitin (Fig. 3C) . Immunogold labeling was absent in sections from non-transgenic and control mice (not shown).
DISCUSSION
This study shows that activated p38MAPK accumulates in the cytoplasm of degenerating motor neurons and astrocytes in both human ALS and transgenic SOD1G93A mice. The most striking observation is the presence of activated p38MAPK in the intracellular skein-like inclusions of human ALS. These are heterogeneous inclusions with an overall filamentous appearance that so far have been only detected with antibodies to ubiquitin and dorfin (4, 6, 11, 12, 22) . Using immunoelectron microscopy techniques, phosphorylated neurofilament epitopes were found at the periphery of the skeins, suggesting that neurofilaments are a component of the inclusions (23) . Phosphorylated neurofilaments are normally distributed along the axon or in the axon terminals. When they become phosphorylated their transport is impaired, leading to accumulation in the perikarya or in the proximal axon (24, 25) . Indeed, direct measurements of axonal transport in several transgenic mouse models of ALS have revealed that slowing of neurofilament transport is a common and early pathological feature (26, 27) . Among the various kinases that are able to phosphorylate neurofilaments in vitro, members of the MAPK family play a relevant role (24) . Recently, we have demonstrated that activated p38MAPK is increased and colocalizes with phosphorylated neurofilaments in vacuolized perikarya and neurites of mutant SOD1 transgenic mice at the very early stages of the disease (17) . This observation suggested that abnormal activation of p38MAPK contributes to the development of degenerative changes in motor neurons (17) . Here, we demonstrate that 1) p38MAPK is activated in degenerating motor neurons and 2) p38MAPK is a component of the intracellular inclusions that characterize the pathology of both human and mouse ALS. In particular, these data clearly show that p38MAPK is a new marker of the skein-like arrays that until now had been only recognized by ubiquitin, dorfin, and neurofilament antibodies (12, 23) .
It has been suggested that MAPK-dependent phosphorylation may lead to protein stabilization (28) and reduced degradation by proteases (29) . Therefore, by phosphorylating neurofilaments and perhaps other cytoplasmic proteins, p38MAPK might promote protein accumulation in cytoplasmic aggregates, leading to motor neuron toxicity and dysfunction (14, 24) .
Accumulation of p38MAPK in motor neurons is at variance with the distribution of JNK, another component of the MAPK family, that is selectively activated in astrocytes but not in motor neurons of ALS patients (21) . The diverse pattern of JNK and p38MAPK localization in pathologically affected regions appears to be characteristic of ALS with respect to other neurodegenerative diseases. In fact, we have recently found that in Alzheimer disease, as well as in other tau-related diseases, both kinases are activated and constantly colocalize with hyperphosphorylated tau in all neuronal and glial inclusions (30) .
Both JNK and p38 MAP kinases play major roles in linking membrane receptors to the transcriptional machinery and to cell death by apoptosis (31), although it is still controversial whether apoptosis is involved in motor neuron death in ALS (20) . Moreover, both kinases are involved in regulating nitric oxide synthase (NOS) expression (32), which has been suggested to play a relevant role in the pathology of ALS (33) . However, our present study indicates that p38MAPK, rather than JNK, is implicated in the mechanism of motor neuron degeneration in ALS. This observation is in line with a recent study showing selective involvement of p38MAPK pathway in the death of cultured primary motor neurons triggered by Fas activation, which is potentiated by ALSlinked SOD1 mutations (34) .
Transcriptional upregulation of neuronal NOS (nNOS) has been proposed as the main mechanism downstream to activation of p38MAPK in the cascade leading to motor neuron death induced by Fas activation (34) . Increased production of nitric oxide (NO), particularly in mutant SOD1-linked ALS, may lead to formation of highly reactive molecules such as peroxynitrite (35) .
Neurofilament light proteins are susceptible to peroxynitrite-mediated nitration, which may contribute to their cytoplasmic accumulation (36) . However, although neurofilament inclusions in ALS are stained with anti-nitrotyrosine antibodies, the extent of nitration of tyrosine residues in the NF-L protein from the spinal cord of sporadic ALS cases did not differ from age-matched controls (37) .
In conclusion, we suggest that activated p38MAPK is a novel marker of the neuronal skein-like inclusions in ALS. Its accumulation in motor neurons with altered morphology, but not in healthy looking motor neurons, suggests that this pathological change may be detrimental for the cells. In view of the potential neurotoxicity of p38MAPK in both human and mouse ALS, this kinase may be considered as a candidate target for therapeutic interventions with p38MAPK inhibitors in ALS patients.
